Benzonatate Capsule
Product Images NDC 71335-0031

2 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Benzonatate (NDC 71335-0031). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl713350031)

Label Image (Lbl713350031)
Benzonatate 200 mg capsule label by Bryant Ranch Prepack. The label includes a purple box with the drug name and strength, directions to compare to Tessalon Pearls 200 mg capsule, and storage instructions to keep at 20-25°C (68-77°F). It also states a warning that the drug may cause drowsiness, lists the quantity as 30 capsules, and shows the product NDC as 71335-0031.*
FDA Label Image

Benzonatate_chem_structure.jpg (Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.